Nike Inc (NKE) 100.33 $NKE Nike Is Showing Continued

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nike Inc (NKE) 100.33 $NKE

Nike Is Showing Continued Growth And Strong Company Performance
LN Investors - at Seeking Alpha - 2 hrs 54 mins ago

NKE: 100.33 (-0.56)

Yoox, Not Amazon, Merges With Retailer Net-A-Porter
at Investor's Business Daily - Tue Mar 31, 12:08PM CDT
On the heels of rumors that e-commerce giant Amazon (AMZN) was looking to buy Net-a-Porter, Yoox has confirmed that it is combining with the popular luxury online retailer in an all-share merger. The new company, Yoox Net-a-Porter, will boast...
AMZN: 372.10 (-2.49), NKE: 100.33 (-0.56)

Cramer -- Limited Upside in J.C. Penney, Under Armour is 'Extraordinary'
at The Street - Tue Mar 31, 9:51AM CDT
TheStreet's Jim Cramer think analysts' bullish sentiment on J.C. Penney is 'gutsy,' but stays optimistic on the growth story for Under Armour and Nike.
UA: 80.75 (+0.84), NKE: 100.33 (-0.56), JCP: 8.41 (+0.58)

Nike (NKE) Stock Climbing Today After Deutsche Bank Price Target Increase
at The Street - Tue Mar 31, 8:58AM CDT
Shares of Nike (NKE) are up after Deutsche Bank raised its price target to $115 from $110, while maintaining its 'buy' rating.
NKE: 100.33 (-0.56)

Deckers Outdoor Vs. Nike: Where Are Investors Better Off Putting Their Money?
Daniel Jones - at Seeking Alpha - Tue Mar 31, 6:55AM CDT

NKE: 100.33 (-0.56), DECK: 72.87 (-0.32)

Jim Cramer's 'Mad Money' Recap: Good Headlines Make All the Difference
at The Street - Mon Mar 30, 7:06PM CDT
It's nice to see the flow of money has reversed from last week's relentless selloff, Cramer says.
D: 70.87 (-0.27), HRS: 78.76 (+1.13), TSLA: 188.77 (-1.80), RH: 99.19 (+0.12), AMZN: 372.10 (-2.49), CTRX: 59.54 (-0.29), BMRN: 124.62 (-4.51), SWKS: 98.29 (-1.84), NKE: 100.33 (-0.56), ED: 61.00 (+0.21), FCAU: 16.31 (-0.24), WDC: 91.01 (-1.92), SLB: 83.44 (-1.04), LULU: 64.02 (-0.81), NFLX: 416.69 (-5.88), AEP: 56.25 (-0.33), XLS: 24.37 (+0.10), TAC: 9.30 (+0.07), AA: 12.92 (-0.04), NBIX: 39.71 (-1.82), CMI: 138.64 (-1.50), ADI: 63.00 (-1.81), HZNP: 25.97 (+0.19), RCPT: 164.89 (+4.84), TEVA: 62.30 (-0.22)

SmarTrend Watching for Potential Pullback in Shares of NIKE After 1.01% Gain
Comtex SmarTrend(R) - Mon Mar 30, 4:15PM CDT
NIKE (NYSE:NKE) traded in a range yesterday that spanned from a low of $100.54 to a high of $101.55. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $101.18 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NKE: 100.33 (-0.56)

NIKE Rises 1.01% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Mar 30, 4:14PM CDT
NIKE (NYSE:NKE) traded in a range yesterday that spanned from a low of $100.54 to a high of $101.55. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $101.18 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NKE: 100.33 (-0.56)

Potential Chinese Stimulus Boosting Stocks, Consolidation in Food Industry to Continue
at The Street - Mon Mar 30, 3:25PM CDT
The CNBC 'Fast Money Halftime' traders meet with leaders at the Morgan Stanley Wealth Management Alternatives Conference in New York City to discuss different strategies.
EWI: 14.80 (-0.18), RH: 99.19 (+0.12), EWG: 29.84 (-0.52), NKE: 100.33 (-0.56), GREK: 11.02 (+0.05), DKS: 56.99 (-0.95), EWQ: 25.98 (-0.40), EWP: 34.78 (-0.25), KRFT: 87.11 (-3.50), DXJS: 33.97 (-0.18), TLT: 130.69 (+0.28), TBT: 41.87 (-0.20), FINL: 24.52 (-0.22), SJM: 115.73 (-1.40), HEWG: 28.54 (-0.35), DXJ: 55.12 (-0.97), UA: 80.75 (+0.84), SPY: 206.43 (-1.82), QQQ: 105.60 (-1.13), EWU: 18.01 (-0.31), DIA: 177.58 (-1.81), EWGS: 39.41 (-0.62), IWM: 124.37 (-0.40), FL: 63.00 (-0.61), FXI: 44.40 (-0.34)

Upgrade Alert for NIKE (NKE)
Comtex SmarTrend(R) - Mon Mar 30, 7:10AM CDT
NIKE (NYSE:NKE) was upgraded from Neutral to Outperform at RW Baird today. The stock closed yesterday at $99.88 on volume of 2.2 million shares, below average daily volume of 4.2 million. NIKE share prices have moved between a 52-week high of $103.79 and a 52-week low of $70.60 and closed yesterday at 41% above that low price at $99.88 per share. Over the last five market days, the 200-day moving average (MA) has gone up 0.7% while the 50-day MA has advanced 0.5%.
NKE: 100.33 (-0.56)

You'll Never Guess Which Country Can't Get Enough of Nike (Hint: It's Not the U.S.)
Steve Symington, The Motley Fool - Motley Fool - Sat Mar 28, 9:03AM CDT
Though Oregon-based  Nike Inc is best known as an American footwear and athletic apparel juggernaut, it's easy to forget the company actually generates more than half its revenue overseas. Last quarter, for example, Nike's international sales...
NKE: 100.33 (-0.56), CS: 26.93 (-0.02)

Dividend Achievers Top 20 Hits The Mark, Again
Dale Roberts - at Seeking Alpha - Sat Mar 28, 1:11AM CDT

MMM: 164.95 (-1.10), GE: 24.81 (-0.31), NKE: 100.33 (-0.56), UTX: 117.20 (-1.63), VIG: 80.47 (-0.77), WMT: 82.25 (-0.28), XOM: 85.00 (-0.63), PEP: 95.62 (-0.90), JNJ: 100.60 (-0.95), T: 32.65 (-0.32), SPY: 206.43 (-1.82), IBM: 160.50 (-2.17), QCOM: 69.34 (+0.46), KO: 40.55 (+0.04), ABT: 46.33 (-0.75), RSP: 81.05 (-0.56), COP: 62.26 (-1.74), WFC: 54.40 (-0.37), VOO: 189.20 (-1.68), TXN: 57.18 (-0.82), MCD: 97.44 (-0.44), CVS: 103.21 (-0.62), AIG: 54.79 (+0.11), PG: 81.94 (-0.78), CVX: 104.98 (-1.92)

Finish Line's Turnaround Is Taking Shape, and Nike and Under Armour Should Only Help
at The Street - Fri Mar 27, 12:37PM CDT
Finish Line finished a challenging year on a solid note. Its CEO explains why better times may be ahead in 2015.
UA: 80.75 (+0.84), NKE: 100.33 (-0.56), DKS: 56.99 (-0.95), FL: 63.00 (-0.61), FINL: 24.52 (-0.22)

Lululemon Up on Q4 Earnings & Sales Beat; Guides FY15 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 27, 8:00AM CDT
Lululemon (LULU) ended fiscal 2014 on a spectacular note.
NKE: 100.33 (-0.56), GIII: 112.65 (+0.18), COLM: 60.90 (-0.61), LULU: 64.02 (-0.81)

Don't Let Low Dividend Yields Keep You From Investing In These Great Companies
Eric Landis - at Seeking Alpha - Fri Mar 27, 7:01AM CDT

TSCO: 85.06 (-1.51), SBUX: 94.70 (-1.28), CHD: 85.42 (-0.51), MON: 112.54 (-0.84), NKE: 100.33 (-0.56), BLK: 365.84 (-2.26), AMP: 130.84 (-0.18), HRL: 56.85 (-0.51), CMCSA: 56.47 (-0.14), UNP: 108.31 (-1.78), ROST: 105.36 (-0.38), PII: 141.10 (-2.29)

Adidas unveils five-year plan
at Investor's Business Daily - Thu Mar 26, 5:32PM CDT
As it lags behind Nike (NKE) and Under Armour (UA) in the American market, Adidas is reportedly testing the use of automated production to speed up its product cycle. The German athletic-wear maker aims to move manufacturing closer to its main...
UA: 80.75 (+0.84), NKE: 100.33 (-0.56)

Finish Line Cutting Fat, Expenses to Win the Retail Race
at The Street - Thu Mar 26, 1:23PM CDT
Investors seeking an undervalued retail name can do well with Finish Line.
UA: 80.75 (+0.84), NKE: 100.33 (-0.56), FINL: 24.52 (-0.22)

How Does Adidas Plan To Knock Out Nike? Robots
at Investor's Business Daily - Thu Mar 26, 1:02PM CDT
Tired of being a bronze medalist, Adidas is looking to call itself the comeback kid with new teammates that will help it gain speed on the playing field: robots. As the athletic apparel brand seeks to move manufacturing closer to its main markets and...
UA: 80.75 (+0.84), NKE: 100.33 (-0.56)

3 Stocks Moving The Consumer Goods Sector Upward
at The Street - Thu Mar 26, 12:03PM CDT
TheStreet highlights 3 stocks pushing the consumer goods sector higher today.
NKE: 100.33 (-0.56), AAPL: 124.43 (-1.94), LULU: 64.02 (-0.81)

Lululemon To Feel Burn From Port Slowdown Through Q2
at Investor's Business Daily - Thu Mar 26, 10:17AM CDT
Lululemon (LULU), like many other retailers, is expected to feel the burn from the West Coast ports slowdown well through the second quarter of fiscal 2015. The recent labor dispute hit a number of companies' outlooks, including those of...
UA: 80.75 (+0.84), NKE: 100.33 (-0.56), M: 64.91 (+0.47), WSM: 79.71 (+0.60), LULU: 64.02 (-0.81)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading